If CXCL8 interacts with the receptor CXCR2, it plays a proangiogenic role, while the opposite role is played when interacting with the DARC receptor, which has been classified as a “silent” receptor that clears ELR+ angiogenic chemokines and inhibits tumor development [12, 13]. This evidence concerns the gene CXCL8 and neoplasm.